FAQ/Help |
Calendar |
Search |
Today's Posts |
|
Parkinson's Disease Clinical Trials For posting and discussion of clinical trials related to Parkinson's Disease, and for the Parkinson Pipeline Project. All are welcome. |
Reply |
|
Thread Tools | Display Modes |
04-20-2009, 10:10 AM | #1 | |||
|
||||
Magnate
|
Impax Pharmaceuticals Reports Positive Achievements on its Two Leading Brand Product Candidates IPX066 and IPX056
Monday April 20, 2009, 8:47 am EDT http://finance.yahoo.com/news/Impax-...0121.html?.v=1 HAYWARD, Calif.--(BUSINESS WIRE)--Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc. (NASDAQ:IPXL - News) today announced it has commenced a Phase III trial of IPX066 in Parkinson’s Disease (PD) patients based on encouraging interim data collected from the Phase II study in PD patients. It also clarified the U.S. Food and Drug Administration (FDA) requirement for pediatric studies of its investigational medication IPX056. A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-Levodopa http://clinicaltrials.gov/ct2/show/NCT00869791 This study is currently recruiting participants. Verified by IMPAX Laboratories, Inc., March 2009 First Received: March 24, 2009 Last Updated: March 25, 2009 Purpose This study compares the pharmacokinetics and effectiveness of IPX066 to standard cabridopa-levodopa Study Type: Interventional Study Design: Treatment, Randomized, Open Label, Active Control, Crossover Assignment, Pharmacokinetics/Dynamics Study Official Title: A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-Levodopa Locations United States, Michigan |
|||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
CLINICAL TRIAL...PHASE III...NET-PD LS-1 Creatine | Parkinson's Disease Clinical Trials | |||
CLINICAL TRIAL...Phase III Trial with Pimavanserin in Patients with PD Psychosis | Parkinson's Disease Clinical Trials | |||
TRIAL: Motor Skill Learning in People with Parkinson’s Disease | Parkinson's Disease Clinical Trials |